West Pharmaceutical ServicesRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
West Pharmaceutical Services (WST) reported revenue of $872.00M in Q2 2026.
West Pharmaceutical ServicesSupplies elastomer stoppers, seals, and self-injection delivery systems for injectable drugs. GLP-1 related high-value product components are about 10% of total revenue and grew in the high teens in Q2 2026, when HVP components rose 18.4% organically and reached 49% of company revenue.
Q3 2024-Q2 2026
Q3 2024-Q2 2026
Q3 2024-Q2 2026
West Pharmaceutical Services (WST) is a Medical - Instruments & Supplies company. Supplies elastomer stoppers, seals, and self-injection delivery systems for injectable drugs. GLP-1 related high-value product components are about 10% of total revenue and grew in the high teens in Q2 2026, when HVP components rose 18.4% organically and reached 49% of company revenue. It was founded in 1923, is headquartered in Exton, PA and employs about 10,800 people.
Track West Pharmaceutical Services's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated July 30, 2026.
Sterling groups West Pharmaceutical Services in the GLP-1 sector, alongside Ypsomed (YPSN.SW), Insulet (PODD) and DexCom (DXCM).
If you are researching West Pharmaceutical Services, also look at Ypsomed (YPSN.SW), Insulet (PODD) and DexCom (DXCM). You can compare all of them side by side or browse the full GLP-1 sector on Sterling.